Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2002 1
2003 2
2004 4
2005 3
2006 3
2007 4
2008 8
2009 10
2010 2
2011 4
2012 2
2013 6
2014 7
2015 3
2016 4
2017 7
2018 7
2019 6
2020 8
2021 9
2022 10
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

105 results

Results by year

Filters applied: . Clear all
Page 1
A global scientific strategy to cure hepatitis B.
Revill PA, Chisari FV, Block JM, Dandri M, Gehring AJ, Guo H, Hu J, Kramvis A, Lampertico P, Janssen HLA, Levrero M, Li W, Liang TJ, Lim SG, Lu F, Penicaud MC, Tavis JE, Thimme R; Members of the ICE-HBV Working Groups; ICE-HBV Stakeholders Group Chairs; ICE-HBV Senior Advisors; Zoulim F. Revill PA, et al. Among authors: tavis je. Lancet Gastroenterol Hepatol. 2019 Jul;4(7):545-558. doi: 10.1016/S2468-1253(19)30119-0. Epub 2019 Apr 10. Lancet Gastroenterol Hepatol. 2019. PMID: 30981686 Free PMC article.
HBV replication inhibitors.
Pierra Rouviere C, Dousson CB, Tavis JE. Pierra Rouviere C, et al. Among authors: tavis je. Antiviral Res. 2020 Jul;179:104815. doi: 10.1016/j.antiviral.2020.104815. Epub 2020 May 5. Antiviral Res. 2020. PMID: 32380149 Free PMC article. Review.
Recent Advances in Hepatitis B Treatment.
Prifti GM, Moianos D, Giannakopoulou E, Pardali V, Tavis JE, Zoidis G. Prifti GM, et al. Among authors: tavis je. Pharmaceuticals (Basel). 2021 May 1;14(5):417. doi: 10.3390/ph14050417. Pharmaceuticals (Basel). 2021. PMID: 34062711 Free PMC article. Review.
Host factor-targeted hepatitis B virus therapies.
Gehring A, Bertoletti A, Tavis JE. Gehring A, et al. Among authors: tavis je. Intervirology. 2014;57(3-4):158-62. doi: 10.1159/000360938. Epub 2014 Jul 15. Intervirology. 2014. PMID: 25034483 Free article. Review.
The hepatitis B virus polymerase.
Clark DN, Tajwar R, Hu J, Tavis JE. Clark DN, et al. Among authors: tavis je. Enzymes. 2021;50:195-226. doi: 10.1016/bs.enz.2021.06.010. Epub 2021 Aug 9. Enzymes. 2021. PMID: 34861937
Shedding light on RNaseH: a promising target for hepatitis B virus (HBV).
Edwards TC, Ponzar NL, Tavis JE. Edwards TC, et al. Among authors: tavis je. Expert Opin Ther Targets. 2019 Jul;23(7):559-563. doi: 10.1080/14728222.2019.1619697. Epub 2019 May 22. Expert Opin Ther Targets. 2019. PMID: 31084514 Free PMC article. No abstract available.
The hepatitis B virus ribonuclease H as a drug target.
Tavis JE, Lomonosova E. Tavis JE, et al. Antiviral Res. 2015 Jun;118:132-8. doi: 10.1016/j.antiviral.2015.04.002. Epub 2015 Apr 8. Antiviral Res. 2015. PMID: 25862291 Free PMC article. Review.
Antiviral Evaluation of Dispirotripiperazines against Hepatitis B Virus.
Jones T, Tavis JE, Li Q, Riabova O, Monakhova N, Bradley DP, Lane TR, Makarov V, Ekins S. Jones T, et al. Among authors: tavis je. J Med Chem. 2023 Sep 14;66(17):12459-12467. doi: 10.1021/acs.jmedchem.3c00974. Epub 2023 Aug 23. J Med Chem. 2023. PMID: 37611244
105 results